Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel · Delayed Price · Currency is ILS · Price in ILA 341.70
-3.10 (-0.90%)
Jul 17, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Revenue
Lineage Cell Therapeutics had revenue of $1.50M USD in the quarter ending March 31, 2025, with 4.02% growth. This brings the company's revenue in the last twelve months to $9.56M, up 19.42% year-over-year. In the year 2024, Lineage Cell Therapeutics had annual revenue of $9.50M with 6.19% growth.
Revenue (ttm)
$9.56M
Revenue Growth
+19.42%
P/S Ratio
20.70
Revenue / Employee
$124.12K
Employees
77
Market Cap
736.66M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.50M | 554.00K | 6.19% |
| Dec 31, 2023 | 8.95M | -5.76M | -39.16% |
| Dec 31, 2022 | 14.70M | 10.36M | 238.70% |
| Dec 31, 2021 | 4.34M | 2.52M | 137.73% |
| Dec 31, 2020 | 1.83M | -1.69M | -48.05% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 61.87B |
| Danel (Adir Yeoshua) | 2.81B |
| Kamada | 622.70M |
| Bait Bakfar | 104.50M |
| SofWave Medical | 235.09M |
| BrainsWay | 161.81M |
| Novolog (Pharm-Up 1966) | 2.07B |
| Ilex Medical | 922.08M |